Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome

Aleksandra Sobolewska-Włodarczyk,1 Marcin Włodarczyk,1 Martin Storr,2 Jakub Fichna1 1Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland; 2Center of Endoscopy, Starnberg, Germany Abstract: Diarrhea-predominant irritable bowel syndrome (IBS-D) belongs to the gr...

Full description

Bibliographic Details
Main Authors: Sobolewska-Włodarczyk A, Włodarczyk M, Storr M, Fichna J
Format: Article
Language:English
Published: Dove Medical Press 2016-05-01
Series:Therapeutics and Clinical Risk Management
Subjects:
eluxadoline
irritable bowel syndrome
diarrhea
abdominal pain
functional gastrointestinal disorders
Online Access:https://www.dovepress.com/clinical-potential-of-eluxadoline-in-the-treatment-of-diarrhea-predomi-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/clinical-potential-of-eluxadoline-in-the-treatment-of-diarrhea-predomi-peer-reviewed-article-TCRM

Similar Items